Today's Stock Analyst Initiations and New Coverage

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ATEC Alphatec	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.23 +6.4%	$15.00	Buy
BBNX Beta Bionics	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.97 -0.1%	$22.00	Buy
BDX Becton, Dickinson and Company	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$167.26 +5.2%		Buy
BLCO Bausch + Lomb	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.63 +2.1%	$21.00	Buy
BNTC Benitec Biopharma	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yun Zhong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.93 +3.0%	$16.00	Outperform
COO Cooper Companies	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$72.33 +2.9%	$75.00	Neutral
EW Edwards Lifesciences	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$84.29 +1.5%	$110.00	Neutral ➝ Buy
FTH Sensei Biotherapeutics	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Olson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.36 -3.0%	$60.00	Outperform
GKOS Glaukos	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$149.69 -1.5%		Buy ➝ Neutral
GMED Globus Medical	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.58 +3.0%	$82.00	Neutral
The Pentagon is desperate (Ad) The Pentagon has admitted the US trails Russia and China in hypersonic weapons, and its research budget has nearly tripled in five years. One small Florida company, trading under $5, is already under contract with Lockheed Martin, GE Aerospace, and the US Air Force to help test this technology at extreme altitudes. The company also launches commercial satellites and is nearing a major licensing milestone that could reshape its valuation. Click here to uncover the hypersonic backdoor company name
GXO GXO Logistics	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christian Wetherbee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.16 -0.3%	$18.00	Overweight
HRB H&R Block	Initiated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wendler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.03 +4.0%	$47.00	Equal Weight
IART Integra LifeSciences	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.46 +4.8%	$19.00	Neutral
INSP Inspire Medical Systems	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.10 +0.3%	$39.00	Sell
KGS Kodiak Gas Services	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derek Podhaizer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.48 -3.9%	$78.00	Overweight
MDCX Medicus Pharma	Initiated by	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$0.29 -7.9%		Buy
MMED MiniMed Group	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.30 +3.6%	$25.00	Buy
RAPP Rapport Therapeutics	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$42.85 +1.7%		Outperform
SGHT Sight Sciences	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.32 +4.0%	$7.00	Buy
SI Shoulder Innovations	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.54 +2.7%	$27.00	Buy
SIBN SiBone	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.10 +6.2%	$24.00	Buy
STAA STAAR Surgical	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.58 -6.0%	$20.00	Sell
STE STERIS	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$228.66 +4.7%	$275.00	Buy
SYK Stryker	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Danielle Antalffy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$351.09 +4.3%	$400.00	Buy
TENX Tenax Therapeutics	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Whitney Ijem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.78 -2.5%	$35.00	Buy
TFX Teleflex	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$135.04 +3.0%	$145.00	Neutral
TMDX TransMedics Group	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$74.83 +0.7%	$80.00	Neutral
TNDM Tandem Diabetes Care	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.88 +4.1%	$18.00	Neutral
ZBH Zimmer Biomet	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$96.95 +5.3%	$115.00	Sell ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:15 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Initiations

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Initiations

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools